PECO ENERGY COMPANY First and Refunding Mortgage Bonds, 5.70% Series Due 2037 Underwriting Agreement
Exhibit 1.1
Execution Version
PECO ENERGY COMPANY
First and Refunding Mortgage Bonds, 5.70% Series Due 0000
Xxxxxxxxxxxx Xxxxxxxxx
Xxx Xxxx, Xxx Xxxx
March 12, 2007
March 12, 2007
To the Representatives named in
Schedule I hereto of the Underwriters
named in Schedule II hereto
Schedule I hereto of the Underwriters
named in Schedule II hereto
Ladies and Gentlemen:
PECO Energy Company, a corporation organized under the laws of the Commonwealth of
Pennsylvania (the “Company”), proposes to sell to the several underwriters named in Schedule II
hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives,
$175,000,000 principal amount of the Company’s First and Refunding Mortgage Bonds, 5.70% Series due
2037 (the “Securities”). The Securities are to be issued under the Company’s First and Refunding
Mortgage, dated as of May 1, 1923 (the “Mortgage”), as amended and supplemented through the date
hereof, and as further amended by the Supplemental Indenture, dated as of March 12, 2007 (the
“Supplement”), between the Company and U.S. Bank National Association, as trustee (the “Trustee”).
The Mortgage, together with any and all amendments or supplements thereto, including the
Supplement, is referred to herein collectively as the “Indenture.” To the extent there are no
additional Underwriters listed on Schedule I other than you, the term Representatives as used
herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean
either the singular or plural as the context requires. Any reference herein to the Registration
Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed
to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form
S-3 which were filed under the Exchange Act on or before the Effective Date of the Registration
Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final
Prospectus, as the case may be; and any reference herein to the terms “amend,” “amendment” or
“supplement” with respect to the Registration Statement, the Base Prospectus, any Preliminary
Prospectus or the Final Prospectus shall be deemed to refer to and include the filing of any
document under the Exchange Act after the Effective Date of the Registration Statement or the issue
date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may
be, deemed to be incorporated therein by reference. Certain terms used herein are defined in
Section 18 hereof.
1. Representations and Warranties. The Company represents and warrants to, and agrees
with, each Underwriter as set forth below in this Section 1.
(a) The Company meets the requirements for use of Form S-3 under the Act and has
prepared and filed with the Commission a registration statement (the file number of which is
set forth in Schedule I hereto) on Form S-3, including a related base prospectus, for
registration under the Act of the offering and sale of the Securities. Such
Registration Statement, including any amendments thereto filed prior to the Execution
Time, has become effective. The Company may have filed one or more amendments thereto,
including a Preliminary Prospectus, each of which has previously been furnished to you. The
Company will next file with the Commission a final term sheet as contemplated by Section
5(b) hereof and a final prospectus supplement relating to the Securities in accordance with
Rules 415 and 424(b). As filed, such final prospectus supplement shall contain all 430B
Information, together with all other such required information, and, except to the extent
the Representatives shall agree in writing to a modification, shall be in all substantive
respects in the form furnished to you prior to the Execution Time or, to the extent not
completed at the Execution Time, shall contain only such specific additional information and
other changes (beyond that contained in the Base Prospectus and any Preliminary Prospectus)
as the Company has advised you, prior to the Execution Time, will be included or made
therein. The Registration Statement, at the Execution Time, meets the requirements set forth
in Rule 415(a)(1)(x).
(b) On the Effective Date, the Registration Statement did, and when the Final
Prospectus is first filed in accordance with Rule 424(b) and on the Closing Date (as defined
herein), the Final Prospectus (and any supplement thereto) will, comply in all material
respects with the applicable requirements of the Act, the Exchange Act and the Trust
Indenture Act and the respective rules thereunder; on the Effective Date and at the
Execution Time, the Registration Statement did not and will not contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or
necessary in order to make the statements therein not misleading; on the Effective Date and
on the Closing Date the Indenture did or will comply in all material respects with the
applicable requirements of the Trust Indenture Act and the rules thereunder; and, on the
date of any filing pursuant to Rule 424(b) and on the Closing Date, the Final Prospectus
(together with any supplement thereto) will not include any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading; provided,
however, that the Company makes no representations or warranties as to (i) that part
of the Registration Statement which shall constitute the Statement of Eligibility and
Qualification (Form T-1) under the Trust Indenture Act of the Trustee or (ii) the
information contained in or omitted from the Registration Statement or the Final Prospectus
(or any supplement thereto) in reliance upon and in conformity with information furnished in
writing to the Company by or on behalf of any Underwriter through the Representatives
specifically for inclusion in the Registration Statement or the Final Prospectus (or any
supplement thereto), it being understood and agreed that the only such information furnished
by or on behalf of any Underwriter consists of the information described as such in Section
8 hereof.
(c) The Disclosure Package did not, as of the time and date designated as the
“Applicable Time of Sale” in Schedule I hereto (the “Applicable Time of Sale”), include an
untrue statement of a material fact or omit to state a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made,
not misleading. The preceding sentence does not apply to statements in or omissions from
the Disclosure Package based upon and in conformity with written information furnished to
the Company by any Underwriter through the Representatives
2
specifically for use therein, it being understood and agreed that the only such
information furnished by or on behalf of any Underwriter consists of the information
described as such in Section 8 hereof.
(d) The Company has not made and will not make (other than the final term sheet
prepared and filed pursuant to Section 5(b) hereof) any offer relating to the Securities
that would constitute a “free writing prospectus” (as defined in Rule 405 under the Act),
without the prior written consent of the Representatives; the Company will comply with the
requirements of Rule 433 under the Act with respect to any such free writing prospectus; any
such free writing prospectus (including the final term sheet prepared and filed pursuant to
Section 5(b) hereof) will not, as of its issue date and through the completion of the public
offer and sale of the Securities, include any information that is inconsistent with the
information contained in the Registration Statement, the Disclosure Package and the Final
Prospectus, and any such free writing prospectus, when taken together with the information
contained in the Registration Statement, the Disclosure Package and the Final Prospectus,
did not, when issued or filed pursuant to Rule 433 under the Act, include an untrue
statement of a material fact or omit to state a material fact necessary to make the
statements therein, in the light of the circumstances under which they were made, not
misleading. For the purpose of clarity, nothing in this Section 1(d) shall restrict the
Company from making any filings required in order to comply with its reporting obligations
under the Exchange Act or the rules and regulations of the Commission promulgated
thereunder.
(e) At the earliest time after the filing of the Registration Statement that the
Company or another offering participant made a bona fide offer of the Securities (within the
meaning of Rule 164(h)(2)) of the Securities Act and (y) as of the Execution Time (with such
date being used as the determination date for purposes of this clause (y)), the Company was
not and is not an Ineligible Issuer (as defined in Rule 405), without taking account of any
determination by the Commission pursuant to Rule 405 that it is not necessary that the
Company be considered an Ineligible Issuer.
(f) The Company is not, and, after giving effect to the offering and sale of the
Securities and the application of the proceeds thereof as described in the Disclosure
Package and the Final Prospectus, will not be required to register as an “investment
company” under the Investment Company Act.
(g) The Company has not taken, directly or indirectly, any action designed to cause or
which has constituted or which might reasonably be expected to cause or result, under the
Exchange Act or otherwise, in the stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of the Securities.
(h) The Company has been duly organized and is validly subsisting as a corporation in
good standing under the laws of the Commonwealth of Pennsylvania with full power and
authority under its articles of incorporation and bylaws to own or lease, as the case may
be, and to operate its properties and conduct its business as described in the Disclosure
Package and the Final Prospectus, and is duly qualified to do business as a foreign entity
and is in good standing under the laws of each jurisdiction which requires
3
such qualification, except where the failure to be so qualified would not reasonably be
expected to have a material adverse effect.
(i) Except as disclosed in the Company’s Form 10-K for the fiscal year ended December
31, 2006, the Company does not have any significant subsidiaries (as such term is defined in
Rule 1.02 of Regulation S-X promulgated under the Act).
(j) The statements in the Disclosure Package and the Final Prospectus under the
headings “Description of the Bonds” and “Description of the First and Refunding Mortgage
Bonds” fairly summarize the matters therein described.
(k) This Agreement has been duly authorized, executed and delivered by the Company; the
Indenture has been duly authorized and, assuming due authorization, execution and delivery
of the Supplement by the Trustee, when executed and delivered by the Company, will
constitute a legal, valid, binding instrument enforceable against the Company in accordance
with its terms (subject, as to the enforcement of remedies, to applicable bankruptcy,
reorganization, insolvency, moratorium or other laws affecting creditors’ rights generally
from time to time in effect and to general principles of equity); the Securities have been
duly authorized, and, when executed and authenticated in accordance with the provisions of
the Indenture and delivered to and paid for by the Underwriters, will have been duly
executed and delivered by the Company and will constitute the legal, valid and binding
obligations of the Company entitled to the benefits of the Indenture (subject, as to the
enforcement of remedies, to applicable bankruptcy, insolvency, moratorium or other laws
affecting creditors’ rights generally from time to time in effect and to general principles
of equity).
(l) The Pennsylvania Public Utility Commission has entered an appropriate order
authorizing the Company to issue and sell the Securities as contemplated herein; such order
is in full force and effect and no proceeding has been initiated upon appeal from or to
review the effectiveness of such order. No other consent, approval, authorization, filing
with or order of any court or state or federal governmental agency or body, including the
Commission and any applicable state regulatory authority, is required in connection with the
transactions contemplated herein or in the Indenture, except such as will be obtained under
the Act, the Trust Indenture Act and the Pennsylvania Public Utility Code, and such as may
be required under the blue sky laws of any jurisdiction in connection with the purchase and
distribution of the Securities by the Underwriters in the manner contemplated by this
Agreement, the Disclosure Package and the Final Prospectus.
(m) Neither the execution and delivery of this Agreement, nor the consummation of any
of the transactions herein contemplated, nor the fulfillment of the terms hereof will
conflict with, result in a breach or violation or imposition of any lien, charge or
encumbrance upon any property or assets of the Company (other than the lien of the
Indenture) pursuant to, (i) the charter or bylaws of the Company; (ii) the terms of any
indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other
agreement, obligation, condition, covenant or instrument to which the Company is a party or
bound or to which its property is subject; or (iii) any statute, law, rule, regulation,
4
judgment, order or decree applicable to the Company of any court, regulatory body,
administrative agency, governmental body, arbitrator or other authority having jurisdiction
over the Company or any of its subsidiaries or any of its or their properties.
(n) The Company has good and sufficient title to all property described or referred to
in the Indenture and purported to be conveyed thereby, subject only to the lien of the
Indenture and excepted encumbrances as therein defined (except as to property released from
the lien of the Indenture in connection with the sale or other disposition thereof, and
certain other exceptions which are not material in the aggregate).
(o) The consolidated historical financial statements and schedules of the Company and
its consolidated subsidiaries included or incorporated by reference in the Disclosure
Package and the Final Prospectus present fairly in all material respects the financial
condition, results of operations and cash flows of the Company as of the date and for the
periods indicated, comply as to form with the applicable accounting requirements of the Act
and have been prepared in conformity with generally accepted accounting principles.
(p) No action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving the Company or any of its subsidiaries or its
or their property is pending or, to the best knowledge of the Company, threatened that (i)
could reasonably be expected to have a material adverse effect on the performance of this
Agreement or the Indenture, or the consummation of any of the transactions contemplated
hereby or thereby; or (ii) could reasonably be expected to have a material adverse effect on
the financial condition, business or properties of the Company and its subsidiaries, taken
as a whole, whether or not arising from transactions in the ordinary course of business,
except as set forth in or contemplated in the Disclosure Package and the Final Prospectus
(exclusive of any amendment or supplement thereto).
(q) PricewaterhouseCoopers LLP, are independent registered public accountants with
respect to the Company within the meaning of the Act and the applicable published rules and
regulations thereunder.
Any certificate signed by any officer of the Company and delivered to the Representatives or
counsel for the Underwriters in connection with the offering of the Securities shall be deemed a
representation and warranty by the Company, as to matters covered thereby, to each Underwriter.
2. Purchase and Sale. Subject to the terms and conditions and in reliance upon the
representations and warranties herein set forth, the Company agrees to sell to each Underwriter,
and each Underwriter agrees, severally and not jointly, to purchase from the Company, at the
purchase price set forth opposite its name in Schedule II hereto, the principal amount of the
Securities set forth opposite such Underwriter’s name in Schedule II hereto.
3. Delivery and Payment. Delivery of and payment for the Securities shall be made on
the date and at the time specified in Schedule I hereto or at such time on such later date not more
than three Business Days after the foregoing date as the Representatives shall
5
designate, which date and time may be postponed by agreement between the Representatives and
the Company or as provided in Section 9 hereof (such date and time of delivery and payment for the
Securities being herein called the “Closing Date”). Delivery of the Securities shall be made to
the Representatives for the respective accounts of the several Underwriters against payment by the
several Underwriters through the Representatives of the purchase price thereof to or upon the order
of the Company by wire transfer payable in same-day funds to an account specified by the Company.
Delivery of the Securities shall be made through the facilities of The Depository Trust Company
unless the Representatives shall otherwise instruct.
4. Offering by Underwriters. It is understood that the several Underwriters propose
to offer the Securities for sale to the public as set forth in the Final Prospectus, the
Preliminary Prospectus and the final term sheet contemplated by Section 5(b) hereof.
5. Agreements. The Company agrees with the several Underwriters that:
(a) Prior to the termination of the offering of the Securities, the Company will not
file any amendment of the Registration Statement or supplement (including the Final
Prospectus or any Preliminary Prospectus) to the Base Prospectus or any Rule 462(b)
Registration Statement unless the Company has furnished you a copy for your review prior to
filing and will not file any such proposed amendment or supplement to which you reasonably
object. The Company will cause the Final Prospectus, properly completed, and any supplement
thereto to be filed with the Commission pursuant to the applicable paragraph of Rule 424(b)
within the time period prescribed and will provide evidence satisfactory to the
Representatives of such timely filing. The Company will promptly advise the Representatives
(1) when the Final Prospectus, and any supplement thereto, shall have been filed (if
required) with the Commission pursuant to Rule 424(b) or when any Rule 462(b) Registration
Statement shall have been filed with the Commission, (2) when, prior to termination of the
offering of the Securities, any amendment to the Registration Statement shall have been
filed or become effective, (3) of any request by the Commission or its staff for any
amendment of the Registration Statement, or any Rule 462(b) Registration Statement, or for
any supplement to the Final Prospectus or for any additional information, (4) of the
issuance by the Commission of any stop order suspending the effectiveness of the
Registration Statement or the institution or threatening of any proceeding for that purpose
and (5) of the receipt by the Company of any notification with respect to the suspension of
the qualification of the Securities for sale in any jurisdiction or the institution or
threatening of any proceeding for such purpose. The Company will use its best efforts to
prevent the issuance of any such stop order or the suspension of any such qualification and,
if issued, to obtain as soon as possible the withdrawal thereof.
(b) The Company shall prepare a final term sheet, containing solely a description of
the Securities, substantially in the form of Annex I hereto and approved by the
Representatives, and shall file such term sheet pursuant to Rule 433(d) under the Act within
the time period prescribed by such rule; and shall file promptly all other material required
to be filed by the Company with the Commission pursuant to Rule 433(d) under the Act.
6
(c) each Underwriter, severally and not jointly, represents and agrees that, without
the prior consent of the Company and the Representatives, it has not made and will not make
any offer relating to the Securities that would constitute a “free writing prospectus” (as
defined in Rule 405 under the Act), other than the final term sheet prepared and filed
pursuant to Section 5(b) hereof or any free writing prospectus that is not required to be
filed by the Company pursuant to Rule 433 (including a preliminary Bloomberg screen
containing substantially the same information, but in any event not more information, than
the final term sheet prepared and filed pursuant to Section 5(b)).
(d) If, at any time when a prospectus relating to the Securities is required to be
delivered under the Act (including circumstances when such requirement may be satisfied
pursuant to Rule 172), any event occurs as a result of which the Final Prospectus as then
supplemented would include any untrue statement of a material fact or omit to state any
material fact necessary to make the statements therein in the light of the circumstances
under which they were made not misleading, or if it shall be necessary to amend the
Registration Statement or supplement the Final Prospectus to comply with the Act or the
Exchange Act or the respective rules thereunder, the Company promptly will (1) notify the
Representatives of such event, (2) prepare and file with the Commission, subject to the
second sentence of paragraph (a) of this Section 5, an amendment or supplement which will
correct such statement or omission or effect such compliance and (3) supply any supplemented
Final Prospectus to you in such quantities as you may reasonably request. If, prior to the
Closing Date, there occurs an event or development as a result of which the Disclosure
Package would include an untrue statement of a material fact or would omit to state a
material fact necessary in order to make the statements therein, in the light of the
circumstances when the Disclosure Package is delivered to a purchaser, not misleading, the
Company promptly will notify the Representatives so that any use of the Disclosure Package
may cease until it is amended or supplemented, and will promptly prepare an amendment or
supplement that will correct such statement or omission.
(e) As soon as practicable, the Company will make generally available to its security
holders and to the Representatives an earnings statement or statements of the Company and
its subsidiaries which will satisfy the provisions of Section 11(a) of the Act and Rule 158
under the Act.
(f) The Company will furnish to the Representatives and counsel for the Underwriters,
without charge, signed copies of the Registration Statement (including exhibits thereto) and
to each other Underwriter a copy of the Registration Statement (without exhibits thereto)
and, so long as delivery of a prospectus by an Underwriter or dealer may be required by the
Act (including circumstances when such requirement may be satisfied pursuant to Rule 172),
as many copies of each Preliminary Prospectus, the Final Prospectus and each Issuer Free
Writing Prospectus and any supplement thereto as the Representatives may reasonably request.
The Company will pay the expenses of printing or other production of all documents relating
to the offering.
(g) The Company will arrange, if necessary, for the qualification of the Securities for
sale under the laws of such jurisdictions as the Representatives may
7
designate, will maintain such qualifications in effect so long as required for the
distribution of the Securities and will pay any fee of the NASD, in connection with its
review of the offering; provided that in no event shall the Company be obligated to qualify
to do business in any jurisdiction where it is not now so qualified or to take any action
that would subject it to service of process in suits, other than those arising out of the
offering or sale of the Securities, in any jurisdiction where it is not now so subject.
(h) The Company will not, without the prior written consent of the Representatives,
offer, sell, contract to sell, pledge, or otherwise dispose of, or enter into any
transaction which is designed to, or might reasonably be expected to, result in the
disposition (whether by actual disposition or effective economic disposition due to cash
settlement or otherwise) by the Company, directly or indirectly, or announce the offering
of, any long-term debt securities issued or guaranteed by the Company or preferred stock
(other than the Securities), until the Business Day set forth on Schedule I hereto.
(i) The Company will not take, directly or indirectly, any action designed to or that
would constitute or that might reasonably be expected to cause or result in, under the
Exchange Act or otherwise, stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of the Securities.
(j) The Company agrees to pay the costs and expenses relating to the following matters:
(i) the preparation of the Supplement, the issuance of the Securities and the fees of the
Trustee; (ii) the preparation, printing or reproduction and filing of the Registration
Statement, each Preliminary Prospectus and Final Prospectus, and each amendment or
supplement to either of them, and any Issuer Free Writing Prospectus; (iii) the printing (or
reproduction) and delivery (including postage, air freight charges and charges for counting
and packaging) of such copies of the Preliminary Prospectus, the Final Prospectus, and all
amendments or supplements to either of them, as may, in each case, be reasonably requested
for use in connection with the offering and sale of the Securities; (iv) the preparation,
printing, authentication, issuance and delivery of certificates for the Securities,
including any stamp or transfer taxes in connection with the original issuance and sale of
the Securities; (v) the printing (or reproduction) and delivery of this Agreement, any blue
sky memorandum and all other agreements or documents printed (or reproduced) and delivered
in connection with the offering of the Securities; (vi) any registration or qualification of
the Securities for offer and sale under the securities or blue sky laws of the several
states (including filing fees and the reasonable fees and expenses of counsel for the
Underwriters relating to such registration and qualification); (vii) the transportation and
other expenses incurred by or on behalf of Company representatives in connection with
presentations to prospective purchasers of the Securities; (viii) the fees and expenses of
the Company’s accountants and counsel (including local and special counsel); (ix) the fees
and expenses of any rating agencies rating the Securities and (x) all other costs and
expenses incident to the performance by the Company of its obligations hereunder.
6. Conditions to the Obligations of the Underwriters. The obligations of the
Underwriters to purchase the Securities shall be subject to the accuracy of the representations and
warranties on the part of the Company contained herein as of the Applicable Time of Sale,
8
the Execution Time and the Closing Date, to the accuracy of the statements of the Company made
in any certificates pursuant to the provisions hereof, to the performance by the Company of its
obligations hereunder and to the following additional conditions:
(a) The Final Prospectus, and any supplement thereto, shall have been filed in the
manner and within the time period required by Rule 424(b); the final term sheet contemplated
by Section 5(b) hereto, and any other material required to be filed by the Company pursuant
to Rule 433(d) under the Act, shall have been filed with the Commission within the
applicable time periods prescribed for such filings by Rule 433; and no stop order
suspending the effectiveness of the Registration Statement or any notice by the Commission
objecting to its use shall have been issued and no proceedings for that purpose shall have
been instituted or threatened.
(b) Xxxxxxx Xxxxx Xxxxxxx & Xxxxxxxxx, LLP, counsel for the Company, shall have
furnished to the Representatives its opinion, dated the Closing Date and addressed to the
Representatives, to the effect that:
(i) the Company has been duly organized and is validly subsisting as a
corporation under the laws of the Commonwealth of Pennsylvania, with full corporate
power and authority under its articles of incorporation to own or lease, as the case
may be, and to operate its properties and conduct its business as described in the
Disclosure Package and the Final Prospectus;
(ii) the Indenture is in due and proper form and has been duly and validly
authorized by the necessary corporate action, by orders duly entered from time to
time by the Pennsylvania Public Utility Commission and has been qualified under the
Trust Indenture Act and no other authorization, approval, consent, certificate or
order of any other state commission or regulatory authority or of any federal
commission or regulatory authority having been required in respect of the execution
and delivery of the Indenture; the Indenture has been duly and validly executed and
delivered and is a valid and enforceable instrument in accordance with its terms
except as the enforceability thereof may be limited by (1) bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium or similar laws of general
applicability relating or affecting the creditors’ rights, (2) applicable state laws
which may affect the remedies provided for in the Indenture without, however,
rendering inadequate, in such counsel’s opinion, the remedies available to the
Trustee for the practical realization of the benefit of the security intended to be
afforded thereby, and (3) general equitable principles, including, without
limitation, concepts of materiality, reasonableness, good faith and fair dealing;
(iii) the Securities are in due and proper form; the issue and sale of the
Securities by the Company in accordance with the terms of this Agreement have been
duly and validly authorized by the necessary corporate action and by orders duly
entered by the Pennsylvania Public Utility Commission, no authorization, approval,
consent, certificate or order of any other state commission or regulatory authority
or of any federal commission or regulatory authority having been
9
required in respect of such issue and sale; the Securities, when duly executed,
authenticated and delivered to the Underwriters against payment of the agreed
consideration therefor, will be valid and enforceable obligations of the Company in
accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium or similar laws of general applicability relating to or
affecting creditors’ rights and to general principles of equity, including, without
limitation, concepts of materiality, reasonableness, good faith and fair dealing;
(iv) the Company has title in fee simple to the real property comprising its
important properties (including interests in properties owned as tenant-in-common
but not including certain of its properties held for electric or gas transmission
lines or water pipelines, which consist of right-of-way easements, and leased
properties), free and clear of liens and encumbrances except (A) the lien of the
Indenture, (B) “excepted encumbrances” as defined in the Indenture, (C) liens,
encumbrances and title defects not discoverable by a diligent search of the public
land records and judgment indexes, and (D) certain other minor exceptions,
restrictions, encumbrances and defects which are of a nature found in properties of
similar character and magnitude, and which, in such counsel’s opinion, do not in any
substantial way impair the security afforded by the Indenture; the property
descriptions in the Indenture (including the general granting clauses) are legally
sufficient to constitute the Indenture a lien on all real property presently owned
by the Company and described therein as subject to the lien thereof; and the real
and personal properties described in the Indenture constitute substantially all the
permanent physical properties and franchises of the Company except (x) such property
as has been duly released from the lien of the Indenture, and (y) certain other
classes of property expressly excepted in the Indenture;
(v) subject to minor exceptions which, in such counsel’s opinion, do not in any
substantial way impair the security afforded by the Indenture, (A) the Indenture
constitutes a valid first mortgage lien of record upon all real property presently
owned by the Company described therein as subject to the lien thereof (other than
properties expressly excepted therefrom, properties properly released from the lien
thereof pursuant to the terms thereof and substantially all of the Company’s
leaseholds), except only as stated in sub-clauses (B), (C), and (D) of paragraph
(iv), and the after-acquired property clauses of the Indenture are effective,
according to their terms, to subject to the lien of the Indenture all after-acquired
real property of the Company located in the Commonwealth of Pennsylvania, subject
(x) to such encumbrances as may exist thereon at the time of the acquisition thereof
and (y) to the due recordation of the Indenture in the counties in which such
after-acquired properties are located; and (B) the Securities are secured by a valid
and, to the extent that it may be perfected by filing under the Uniform Commercial
Code, a perfected security interest in such of the personal property of the Company
as is described in the Indenture, whether such personal property is now owned or
hereinafter acquired by the Company (other than properties expressly excepted
therefrom; properties released from the
10
security interest created thereby; “proceeds” as defined in the Uniform
Commercial Code to the extent limited by the terms of Section 9-315 of the Uniform
Commercial Code; after-acquired property subject to Section 552 of the Federal
Bankruptcy Code; property sold to a buyer in the ordinary course of business,
licensed to a licensee in the ordinary course of business or leased to a lessee in
the ordinary course of business; insurance policies (except to the extent that
payments thereunder are “proceeds,” as defined in the Uniform Commercial Code); and
contract rights or general intangibles which by their terms, or by law, are not
assignable), which security interest is prior to any other security interest other
than (1) “excepted encumbrances” as defined in the Indenture, (2) rights created and
security interests perfected other than by filing pursuant to the Uniform Commercial
Code, (3) present or future purchase money security interests, (4) security
interests in collateral which qualifies for priority over a conflicting security
interest as provided in Sections 9-322, 9-328, 9-329, 9-330 and 9-331 of the Uniform
Commercial Code, (5) security interests perfected under a certificate of title
statute with respect to property that becomes an accession under Section 9-335 of
the Uniform Commercial Code, and (6) perfected security interests to which property
hereafter acquired by the Company is subject at the time of such acquisition; such
counsel need express no opinion as to any actions that may be required to be taken
periodically under the Uniform Commercial Code or other applicable law in order for
the validity or perfection of any security interest to be maintained;
(vi) to the knowledge of such counsel, there are no material pending legal
proceedings to which the Company or any subsidiary is a party and which are required
to be set forth in the documents incorporated by reference in the Registration
Statement and Final Prospectus other than those referred to in such documents; and
the statements in any Preliminary Prospectus and the Final Prospectus under the
headings “Description of the Bonds” and “Description of the First and Refunding
Mortgage Bonds” fairly summarize the matters therein described;
(vii) the Registration Statement has become effective under the Act; any
required filing of the Base Prospectus, any Preliminary Prospectus and the Final
Prospectus, and any supplements thereto, pursuant to Rule 424(b) has been made in
the manner and within the time period required by Rule 424(b); to the knowledge of
such counsel, no stop order suspending the effectiveness of the Registration
Statement or any notice by the Commission objecting to its use has been issued, no
proceedings for that purpose have been instituted or threatened, and the
Registration Statement and the Final Prospectus (other than the financial statements
and other financial information contained therein, as to which such counsel need
express no opinion) comply as to form in all material respects with the applicable
requirements of the Act, the Exchange Act and the Trust Indenture Act and the
respective rules thereunder; and such counsel has no reason to believe that on the
Effective Date the Registration Statement contained any untrue statement of a
material fact or omitted to state any material fact required to be stated therein or
necessary to make the statements therein not misleading or that
11
the Final Prospectus as of its date and on the Closing Date included or
includes any untrue statement of a material fact or omitted or omits to state a
material fact necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading (in each case, other than
the financial statements and other financial information contained therein, as to
which such counsel need express no opinion);
(viii) such counsel has no reason to believe that the Disclosure Package, as of
the Applicable Time of Sale, contained any untrue statement of a material fact or
omitted to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading (other than the financial statements and other financial information
contained therein, as to which such counsel need express no opinion)
(ix) this Agreement has been duly authorized, executed and delivered by the
Company;
(x) the Company is not and, after giving effect to the offering and sale of the
Securities and the application of the proceeds thereof as described in the
Disclosure Package and the Final Prospectus, will not be required to register as an
“investment company” under the Investment Company Act of 1940, as amended;
(xi) the Pennsylvania Public Utility Commission has entered an appropriate
order authorizing the Company to issue and sell the Securities as contemplated
herein; such order is in full force and effect and, to the best of such counsel’s
knowledge after due inquiry, no proceeding has been initiated upon appeal from or to
review the effectiveness of such order; no other consent, approval, authorization,
filing with or order of any court or state or federal governmental agency or body is
required in connection with the transactions contemplated herein or in the
Indenture, except such as have been obtained under the Act, the Trust Indenture Act,
and from the Pennsylvania Public Utility Commission, and such as may be required
under the blue sky or securities laws of any jurisdiction in connection with the
purchase and sale of the Securities by the Underwriters in the manner contemplated
in this Agreement and the Final Prospectus and such other approvals (specified in
such opinion) as have been obtained; and
(xii) neither the execution and delivery of this Agreement or the Supplement,
nor the consummation of any other of the transactions herein contemplated, nor the
fulfillment of the terms hereof or thereof will contravene, result in a breach or
violation of, or imposition of any lien, charge or encumbrance upon any property or
asset of the Company (other than the lien of the Indenture) pursuant to, (i) the
articles of incorporation and bylaws of the Company; (ii) the terms of any
indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement
or other agreement, obligation, condition, covenant or instrument to which the
Company is a party or bound or to which its property is subject that is listed in
the Exhibit Index to the Company’s Form 10-K
12
for the fiscal year ended December 31, 2006 and Forms 8-K filed with the
Commission during the period between January 1, 2007 and the Closing Date; or (iii)
any statute, law, rule, regulation, judgment, order or decree applicable to the
Company of any court, regulatory body, administrative agency, governmental body,
arbitrator or other authority having jurisdiction over the Company or any of its
properties.
In rendering such opinion, such counsel may rely (A) as to matters involving the application
of laws of any jurisdiction other than the Commonwealth of Pennsylvania or the Federal laws
of the United States, to the extent they deem proper and specified in such opinion, upon the
opinion of other counsel of good standing whom they believe to be reliable and who are
satisfactory to counsel for the Underwriters and (B) as to matters of fact, to the extent
they deem proper, on certificates of responsible officers of the Company and public
officials. References to the Final Prospectus in this paragraph (b) include any supplements
thereto at the Closing Date.
(c) The Representatives shall have received from Winston & Xxxxxx LLP, counsel for the
Underwriters, such opinion or opinions, dated the Closing Date and addressed to the
Representatives, with respect to the issuance and sale of the Securities, the Indenture, the
Registration Statement, the Final Prospectus (together with any supplement thereto) and
other related matters as the Representatives may reasonably require, and the Company shall
have furnished to such counsel such documents as they request for the purpose of enabling
them to pass upon such matters.
(d) The Company shall have furnished to the Representatives a certificate of the
Company, signed by the Chairman of the Board or the President and the principal financial or
accounting officer of the Company, dated the Closing Date, to the effect that the signers of
such certificate have carefully examined the Registration Statement, the Disclosure Package,
the Final Prospectus and any amendment or supplement thereto and that:
(i) the representations and warranties of the Company in this Agreement are
true and correct in all material respects on and as of the Closing Date with the
same effect as if made on the Closing Date and the Company has complied with all the
agreements and satisfied all the conditions on its part to be performed or satisfied
at or prior to the Closing Date;
(ii) no stop order suspending the effectiveness of the Registration Statement
or any notice by the Commission objecting to its use has been issued and no
proceedings for that purpose have been instituted or, to the Company’s knowledge,
threatened; and
(iii) since the date of the most recent financial statements included or
incorporated by reference in the Disclosure Package and the Final Prospectus
(exclusive of any supplement thereto), there has been no material adverse effect on
the financial condition, business or properties of the Company and its subsidiaries,
taken as a whole, whether or not arising from transactions in the
13
ordinary course of business, except as set forth in or contemplated in the
Disclosure Package and the Final Prospectus (exclusive of any supplement thereto).
(e) At the Execution Time and at the Closing Date, the Company shall have requested and
caused PricewaterhouseCoopers LLP to furnish to the Representatives letters, dated
respectively as of the Execution Time and as of the Closing Date, in form and substance
satisfactory to the Representatives.
(f) Subsequent to the Execution Time or, if earlier, the dates as of which information
is given in the Registration Statement (exclusive of any amendment thereof), the Disclosure
Package and the Final Prospectus (exclusive of any amendment or supplement thereto), there
shall not have been (i) any change or decrease specified in the letter or letters referred
to in paragraph (e) of this Section 6 or (ii) any change, or any development involving a
prospective change, in or affecting the financial condition, business or properties of the
Company and its subsidiaries, taken as a whole, whether or not arising from transactions in
the ordinary course of business, except as set forth in or contemplated in the Disclosure
Package or the Final Prospectus (exclusive of any amendment or supplement thereto) the
effect of which, in any case referred to in clause (i) or (ii) above, is, in the sole
judgment of the Representatives, so material and adverse as to make it impractical or
inadvisable to proceed with the offering or delivery of the Securities as contemplated by
the Registration Statement (exclusive of any amendment thereof), the Disclosure Package and
the Final Prospectus (exclusive of any amendment or supplement thereto).
(g) On the Closing Date, (i) the Securities shall be rated “A2” by Xxxxx’x Investors
Service, Inc., “A-” by Standard & Poor’s Ratings Services and “A” by Fitch, Inc.,
respectively, and the Company shall have delivered to the Representatives evidence
satisfactory to the Representatives confirming that the Securities have such ratings, and
(ii) since the Execution Time, there shall not have occurred a downgrading in the rating
assigned to the Securities or any of the Company’s first mortgage bonds or commercial paper
by any “nationally recognized statistical rating agency,” as that term is defined by the
Commission for purposes of Rule 436(g)(2) under the Act, and no such securities rating
agency shall have publicly announced that it has under surveillance or review, with possible
negative implications, its rating of the Securities or any of the Company’s other debt
securities.
(h) Prior to the Closing Date, the Company shall have furnished to the Representatives
such further information, certificates and documents as the Representatives may reasonably
request.
If any of the conditions specified in this Section 6 shall not have been fulfilled in all
material respects when and as provided in this Agreement, or if any of the opinions and
certificates mentioned above or elsewhere in this Agreement shall not be in all material respects
reasonably satisfactory in form and substance to the Representatives and counsel for the
Underwriters, this Agreement and all obligations of the Underwriters hereunder may be canceled
14
at, or at any time prior to, the Closing Date by the Representatives. Notice of such
cancelation shall be given to the Company in writing or by telephone or facsimile confirmed in
writing.
The documents required to be delivered by this Section 6 will be delivered at the office of
counsel for the Company, at Xxxxxxx Xxxxx Xxxxxxx & Xxxxxxxxx, LLP, 0000 Xxxxxx Xxxxxx, 00xx Xxxxx,
Xxxxxxxxxxxx, Xxxxxxxxxxxx 00000, on the Closing Date.
7. Reimbursement of Underwriters’ Expenses. If the sale of the Securities provided
for herein is not consummated because any condition to the obligations of the Underwriters set
forth in Section 6 hereof is not satisfied, because of any termination pursuant to Section 10
hereof or because of any refusal, inability or failure on the part of the Company to perform any
agreement herein or comply with any provision hereof other than by reason of a default by any of
the Underwriters, the Company will reimburse the Underwriters severally upon demand for all
out-of-pocket expenses (including fees and disbursements of counsel reasonably incurred) that shall
have been incurred by them in connection with the proposed purchase and sale of the Securities.
8. Indemnification and Contribution. (a) The Company agrees to indemnify and hold
harmless each Underwriter, the directors, officers, employees and agents of each Underwriter and
each person who controls any Underwriter within the meaning of either the Act or the Exchange Act
against any and all losses, claims, damages or liabilities, joint or several, to which they or any
of them may become subject under the Act, the Exchange Act or other Federal or state statutory law
or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities
(or actions in respect thereof) (i) arise out of or are based upon any untrue statement or alleged
untrue statement of a material fact contained in the registration statement for the registration of
the Securities as originally filed or in any amendment thereof, or arise out of or are based upon
an omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, or (ii) arise out of or are based upon any
untrue statement or alleged untrue statement of a material fact, in light of the circumstances in
which it was made, or an omission or alleged omission to state a material fact required to be
stated or necessary to make the statements therein, in light of the circumstances in which they
were made, not misleading, in any Preliminary Prospectus, the Final Prospectus, or in any amendment
or supplement thereto, or in any Issuer Free Writing Prospectus or any “issuer information” filed
or required to be filed pursuant to Rule 433(d) under the Act, and agrees to reimburse each such
indemnified party, as incurred, for any legal or other expenses reasonably incurred by them in
connection with investigating or defending any such loss, claim, damage, liability or action;
provided, however, that the Company will not be liable in any such case to the
extent that any such loss, claim, damage or liability arises out of or is based upon any such
untrue statement or alleged untrue statement or omission or alleged omission made therein in
reliance upon and in conformity with written information furnished to the Company by or on behalf
of any Underwriter through the Representatives specifically for inclusion therein.
(b) Each Underwriter severally and not jointly agrees to indemnify and hold harmless
the Company, each of its directors, each of its officers, and each person who controls the
Company within the meaning of either the Act or the Exchange Act, to the same extent as the
foregoing indemnity from the Company to each Underwriter, but only with reference to written
information relating to such Underwriter furnished to the
15
Company by or on behalf of such Underwriter through the Representatives specifically
for inclusion in the documents referred to in Section 8(a) above. This indemnity agreement
will be in addition to any liability which any Underwriter may otherwise have. The Company
acknowledges that (i) the statement set forth on the cover page regarding delivery of the
Securities and (ii) under the heading “Underwriting,” (A) the list of Underwriters and their
respective participation in the sale of the Securities, (B) the sentences related to
concessions and reallowances and (C) the paragraph related to stabilization, syndicate
covering transactions and penalty bids in any Preliminary Prospectus and the Final
Prospectus constitute the only information furnished in writing by or on behalf of the
several Underwriters for inclusion in any Preliminary Prospectus, the Final Prospectus or
any Issuer Free Writing Prospectus.
(c) Promptly after receipt by an indemnified party under this Section 8 of notice of
the commencement of any action, such indemnified party will, if a claim in respect thereof
is to be made against the indemnifying party under this Section 8, notify the indemnifying
party in writing of the commencement thereof; but the failure so to notify the indemnifying
party (i) will not relieve it from liability under paragraph (a) or (b) above unless and to
the extent it did not otherwise learn of such action and such failure results in the
forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not,
in any event, relieve the indemnifying party from any obligations to any indemnified party
other than the indemnification obligation provided in paragraph (a) or (b) above. The
indemnifying party shall be entitled to appoint counsel of the indemnifying party’s choice
at the indemnifying party’s expense to represent the indemnified party in any action for
which indemnification is sought (in which case the indemnifying party shall not thereafter
be responsible for the fees and expenses of any separate counsel retained by the indemnified
party or parties except as set forth below); provided, however, that such
counsel shall be satisfactory to the indemnified party. Notwithstanding the indemnifying
party’s election to appoint counsel to represent the indemnified party in an action, the
indemnified party shall have the right to employ separate counsel (including local counsel),
and the indemnifying party shall bear the reasonable fees, costs and expenses of such
separate counsel if (i) the use of counsel chosen by the indemnifying party to represent the
indemnified party would present such counsel with a conflict of interest, (ii) the actual or
potential defendants in, or targets of, any such action include both the indemnified party
and the indemnifying party and the indemnified party shall have reasonably concluded that
there may be legal defenses available to it and/or other indemnified parties which are
different from or additional to those available to the indemnifying party, (iii) the
indemnifying party shall not have employed counsel satisfactory to the indemnified party to
represent the indemnified party within a reasonable time after notice of the institution of
such action or (iv) the indemnifying party shall authorize the indemnified party to employ
separate counsel at the expense of the indemnifying party. An indemnifying party will not,
without the prior written consent of the indemnified parties, settle or compromise or
consent to the entry of any judgment with respect to any pending or threatened claim,
action, suit or proceeding in respect of which indemnification or contribution may be sought
hereunder (whether or not the indemnified parties are actual or potential parties to such
claim or action) unless such settlement, compromise or consent includes an unconditional
release of each
16
indemnified party from all liability arising out of such claim, action, suit or
proceeding and does not include a statement as to, or admission of, fault, culpability or
failure to act on behalf of any indemnified party.
(d) In the event that the indemnity provided in paragraph (a) or (b) of this Section 8
is for any reason held to be unenforceable by an indemnified party or is insufficient to
hold harmless a party indemnified under paragraph (a) or (b) of this Section 8, although
applicable in accordance with its terms (including the requirements of Section 8(c) above),
the Company and the Underwriters severally agree to contribute to the aggregate losses,
claims, damages and liabilities (including legal or other expenses reasonably incurred in
connection with investigating or defending same) (collectively “Losses”) to which the
Company and one or more of the Underwriters may be subject in such proportion as is
appropriate to reflect the relative benefits received by the Company on the one hand and by
the Underwriters on the other from the offering of the Securities; provided,
however, that in no case shall any Underwriter (except as may be provided in any
agreement among underwriters relating to the offering of the Securities) be responsible for
any amount in excess of the underwriting discount or commission applicable to the Securities
purchased by such Underwriter hereunder; provided, further, that each
Underwriter’s obligation to contribute to Losses hereunder shall be several and not joint.
If the allocation provided by the immediately preceding sentence is unavailable for any
reason, the Company and the Underwriters severally shall contribute in such proportion as is
appropriate to reflect not only such relative benefits but also the relative fault of the
Company on the one hand and of the Underwriters on the other in connection with the
statements or omissions which resulted in such Losses as well as any other relevant
equitable considerations. Benefits received by the Company shall be deemed to be equal to
the total net proceeds from the offering (before deducting expenses) received by it, and
benefits received by the Underwriters shall be deemed to be equal to the total underwriting
discounts and commissions, in each case as set forth on the cover page of the Final
Prospectus. Relative fault shall be determined by reference to, among other things, whether
any untrue or any alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information provided by the Company on the one
hand or the Underwriters on the other, the intent of the parties and their relative
knowledge, access to information and opportunity to correct or prevent such untrue statement
or omission. The Company and the Underwriters agree that it would not be just and equitable
if contribution were determined by pro rata allocation or any other method of allocation
which does not take account of the equitable considerations referred to above.
Notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. For
purposes of this Section 8, each person who controls an Underwriter within the meaning of
either the Act or the Exchange Act and each director, officer, employee and agent of an
Underwriter shall have the same rights to contribution as such Underwriter, and each person
who controls the Company within the meaning of either the Act or the Exchange Act, each
officer of the Company and each director of the Company shall have the same rights to
contribution as the Company, subject in each case to the applicable terms and conditions of
this paragraph (d).
17
9. Default by an Underwriter. If any one or more Underwriters shall fail to purchase
and pay for any of the Securities agreed to be purchased by such Underwriter or Underwriters
hereunder and such failure to purchase shall constitute a default in the performance of its or
their obligations under this Agreement, the remaining Underwriters shall be obligated severally to
take up and pay for (in the respective proportions which the principal amount of Securities set
forth opposite their names in Schedule II hereto bears to the aggregate principal amount of
Securities set forth opposite the names of all the remaining Underwriters) the Securities which the
defaulting Underwriter or Underwriters agreed but failed to purchase; provided,
however, that in the event that the aggregate principal amount of Securities which the
defaulting Underwriter or Underwriters agreed but failed to purchase shall exceed 10% of the
aggregate principal amount of Securities set forth in Schedule II hereto, the remaining
Underwriters shall have the right to purchase all, but shall not be under any obligation to
purchase any, of the Securities, and if such nondefaulting Underwriters do not purchase all the
Securities, this Agreement will terminate without liability to any nondefaulting Underwriter or the
Company. In the event of a default by any Underwriter as set forth in this Section 9, the Closing
Date shall be postponed for such period, not exceeding five Business Days, as the Representatives
shall determine in order that the required changes in the Registration Statement and the Final
Prospectus or in any other documents or arrangements may be effected. Nothing contained in this
Agreement shall relieve any defaulting Underwriter of its liability, if any, to the Company and any
nondefaulting Underwriter for damages occasioned by its default hereunder.
10. Termination. This Agreement shall be subject to termination in the absolute
discretion of the Representatives, by notice given to the Company prior to delivery of and payment
for the Securities, if (A) at any time prior to such time (i) trading in the common stock of Exelon
Corporation shall have been suspended by the Commission or the New York Stock Exchange, or trading
in securities generally on the New York Stock Exchange shall have been suspended or limited or
minimum prices shall have been established on such Exchange, (ii) a banking moratorium shall have
been declared either by Federal or New York State authorities, (iii) a major disruption of
settlements of securities or clearance services in the United States shall have occurred or (iv)
there shall have occurred any outbreak or escalation of hostilities, declaration by the United
States of a national emergency or war, or other calamity or crisis and (B) the effect of the event
as set forth in the foregoing clauses (iii) and (iv), as the case may be, on the financial markets
is such as to make it, in the sole judgment of the Representatives, impractical or inadvisable to
proceed with the offering or delivery of the Securities as contemplated by the Disclosure Package
and the Final Prospectus (exclusive of any supplement thereto).
11. Representations and Indemnities to Survive. The respective agreements,
representations, warranties, indemnities and other statements of the Company or its officers and of
the Underwriters set forth in or made pursuant to this Agreement will remain in full force and
effect, regardless of any investigation made by or on behalf of any Underwriter or the Company or
any of the officers, directors, employees, agents or controlling persons referred to in Section 8
hereof, and will survive delivery of and payment for the Securities. The provisions of Sections 7
and 8 hereof shall survive the termination or cancellation of this Agreement.
12. Notices. All communications hereunder will be in writing and effective only on
receipt, and, if sent to the Representatives, will be mailed, delivered or telefaxed to
00
Xxxxxxxxx Xxxxxxx Xxxxxxx, Inc., 000 Xxxxxxxxx Xxxx, Xxxxxxxxx, Xxxxxxxxxxx 00000, Attention:
Xxxxxxxx Xxxxxx (fax no.: (000)000-0000) and Xxxxx Xxxxxx (fax no.: (000) 000-0000), and X.X.
Xxxxxx Securities Inc., 000 Xxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx, Attention: High Grade Syndicate
Desk—8th Floor (fax no.: (000) 000-0000); or, if sent to the Company, will be mailed,
delivered or telefaxed to Exelon Corporation, 00 Xxxxx Xxxxxxxx Xxxxxx, 00xx Floor, X.X. Xxx
000000, Xxxxxxx, Xxxxxxxx 00000-0000, Attention: Vice President and Treasurer (fax no.: (000)
000-0000) and confirmed to the General Counsel (fax no.: (000) 000-0000).
13. Successors. This Agreement will inure to the benefit of and be binding upon the
parties hereto and their respective successors and the officers, directors, employees, agents and
controlling persons referred to in Section 8 hereof, and no other person will have any right or
obligation hereunder.
14. No Fiduciary Duty. The Company hereby acknowledges that (a) the purchase and sale
of the Securities pursuant to this Agreement is an arm’s-length commercial transaction between the
Company, on the one hand, and the Underwriters and any affiliate through which it may be acting, on
the other, (b) the Underwriters are acting as principal and not as an agent or fiduciary of the
Company and (c) the Company’s engagement of the Underwriters in connection with the offering and
the process leading up to the offering is as independent contractors and not in any other capacity.
Furthermore, the Company agrees that it is solely responsible for making its own judgments in
connection with the offering (irrespective of whether any of the Underwriters has advised or is
currently advising the Company on related or other matters). The Company agrees that it will not
claim that the Underwriters have rendered advisory services of any nature or respect, or owe an
agency, fiduciary or similar duty to the Company, in connection with such transaction or the
process leading thereto.
15. Applicable Law. This Agreement will be governed by and construed in accordance
with the laws of the State of New York applicable to contracts made and to be performed within the
State of New York.
16. Counterparts. This Agreement may be signed in one or more counterparts, each of
which shall constitute an original and all of which together shall constitute one and the same
agreement.
17. Headings. The section headings used herein are for convenience only and shall not
affect the construction hereof.
18. Definitions. The terms which follow, when used in this Agreement, shall have the
meanings indicated.
“Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations
of the Commission promulgated thereunder.
“Agreement” shall mean this Underwriting Agreement including all schedules attached
hereto and made a part hereof.
“Base Prospectus” shall mean the base prospectus referred to in paragraph 1(a) above
contained in the Registration Statement at the Effective Time.
19
“Business Day” shall mean any day other than a Saturday, a Sunday or a legal holiday or
a day on which banking institutions or trust companies are authorized or obligated by law to
close in New York City.
“Commission” shall mean the Securities and Exchange Commission.
“Disclosure Package” shall mean (i) the Preliminary Prospectus, including the Base
Prospectus, as amended and supplemented to the Applicable Time of Sale, (ii) the final term
sheet prepared and filed pursuant to Section 5(b) hereof, (iii) any Issuer Free Writing
Prospectus and (iv) any other Free Writing Prospectus that the parties hereto shall
hereafter expressly agree in writing to treat as part of the Disclosure Package.
Notwithstanding any provision hereof to the contrary, each document included in the
Disclosure Package shall be deemed to include all documents incorporated therein by
reference, whether any such incorporated document is filed before or after the document into
which it is incorporated, so long as the incorporated document is filed before the
Applicable Time of Sale.
“Effective Date” shall mean each date and time that the Registration Statement, any
post-effective amendment or amendments thereto and any Rule 462(b) Registration Statement
became or becomes effective.
“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the
rules and regulations of the Commission promulgated thereunder.
“Execution Time” shall mean the date and time that this Agreement is executed and
delivered by the parties hereto.
“Final Prospectus” shall mean the prospectus supplement relating to the Securities that
was first filed pursuant to Rule 424(b) after the Execution Time, together with the Base
Prospectus.
“Investment Company Act” shall mean the Investment Company Act of 1940, as amended, and
the rules and regulations of the Commission promulgated thereunder.
“Issuer Free Writing Prospectus” shall mean any “issuer free writing prospectus” as
defined in Rule 433 under the Act.
“NASD” shall mean the National Association of Securities Dealers, Inc.
“Preliminary Prospectus” shall mean any preliminary prospectus supplement to the Base
Prospectus which describes the Securities and the offering thereof and is used prior to the
filing of the Final Prospectus, together with the Base Prospectus.
“Registration Statement” shall mean the registration statement referred to in paragraph
1(a) above, including exhibits and financial statements and any prospectus supplement
relating to the Securities that is filed with the Commission pursuant to Rule 424(b) and
deemed part of such registration statement pursuant to Rule 430B, as amended on the
Effective Date and, in the event any post-effective amendment thereto or
20
any Rule 462(b) Registration Statement becomes effective prior to the Closing Date,
shall also mean such registration statement as so amended or such Rule 462(b) Registration
Statement, as the case may be.
“Rule 158,” “Rule 164,” “Rule 172,” “Rule 405,” “Rule 415,” “Rule 424,” “Rule 430B” and
“Rule 462” refer to such rules under the Act.
“Rule 430B Information” shall mean information with respect to the Securities and the
offering thereof permitted to be omitted from the Registration Statement when it becomes
effective pursuant to Rule 430B.
“Rule 462(b) Registration Statement” shall mean a registration statement and any
amendments thereto filed pursuant to Rule 462(b) relating to the offering covered by the
registration statement referred to in Section 1(a) hereof.
“Trust Indenture Act” shall mean the Trust Indenture Act of 1939, as amended and the
rules and regulations of the Commission promulgated thereunder.
21
If the foregoing is in accordance with your understanding of our agreement, please sign and
return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall
represent a binding agreement among the Company and the several Underwriters.
Very truly yours, PECO ENERGY COMPANY |
||||
By: | ||||
Name: | ||||
Title: | ||||
The foregoing Agreement is hereby confirmed and accepted as of the date specified in Schedule I hereto. | ||||
GREENWICH CAPITAL MARKETS, INC. | ||||
By: |
||||
Title: | ||||
X.X. XXXXXX SECURITIES INC. | ||||
By: |
||||
Title: | ||||
For themselves and the other several Underwriters named in Schedule II to the foregoing Agreement. |
SCHEDULE I
Underwriting Agreement, dated March 12, 2007
Registration Statement No. 333-105207
Representatives: Greenwich Capital Market, Inc. and X.X. Xxxxxx Securities Inc.
Title, Purchase Price and Description of Securities:
Title: First and Refunding Mortgage Bonds, 5.70% Series due 2037
Principal amount: $175,000,000
Purchase price (include accrued
interest or amortization, if
any): 99.474%
interest or amortization, if
any): 99.474%
Underwriting Discount: .875%
Sinking fund provisions: None
Redemption provisions: As set forth in the Final Prospectus
Other provisions: As set forth in the Final Prospectus
Closing Date, Time and Location: | March 19, 2007 at approximately 11:00 a.m. EDT Xxxxxxx Xxxxx Xxxxxxx & Xxxxxxxxx, LLP 0000 Xxxxxx Xxxxxx, 00xx Xxxxx Xxxxxxxxxxxx, Xxxxxxxxxxxx 00000 |
Type of Offering: Non-delayed
Applicable Time of Sale pursuant to Section 2(c) of the Underwriting Agreement: 12:45 p.m. EDT,
Monday, March 12, 2007
SCHEDULE II
Principal Amount | ||||
of Securities to | ||||
Underwriters | be Purchased | |||
X.X. Xxxxxx Securities Inc. |
$ | 61,250,000 | ||
Greenwich Capital Markets, Inc. |
$ | 61,250,000 | ||
Dresdner Kleinwort Securities LLC |
$ | 15,750,000 | ||
KeyBank Capital Markets, a division of McDonald Investments, Inc. |
$ | 15,750,000 | ||
CastleOak Securities, L.P. |
$ | 10,500,000 | ||
Loop Capital Markets, LLC |
$ | 10,500,000 | ||
Total |
$ | 175,000,000 | ||
Annex I
PECO Energy Company
Pricing Term Sheet
Issuer: |
PECO Energy Company | |
Size: |
$175,000,000 | |
Maturity: |
March 15, 2037 | |
Coupon: |
5.70% | |
Price to Public: |
99.474% of face amount | |
Yield to maturity: |
5.737% | |
Spread to Benchmark Treasury: |
+ 102 basis points | |
Benchmark Treasury: |
4.500% due February 15, 2036 | |
Benchmark Treasury Yield: |
4.717% | |
Interest Payment Dates: |
March 15 and September 15, commencing September 15, 2007 | |
Redemption Provisions: |
||
Make-whole call |
At any time at a discount rate of Treasury plus 20 basis points | |
Settlement: |
March 19, 2007 | |
CUSIP: |
000000XX0 / US693304AJ61 | |
Ratings: |
A2 (Xxxxx’x); A- (S&P); A (Fitch) |
Note: A securities rating is not a recommendation to buy, sell or hold
securities and may be subject to revision or withdrawal at any time.
The issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus in
that registration statement and other documents the issuer has filed with the SEC for more complete
information about the issuer and this offering. You may get these documents for free by visiting
XXXXX on the SEC Web site at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or
any dealer participating in the offering will arrange to send you the prospectus if you request it
by calling X.X. Xxxxxx Securities Inc. collect at (000) 000-0000 or by contacting RBS Greenwich
Capital by telephone (toll free) at 0-000-000-0000 or by email at
xxxxxxxxxxxxxxxxx@xxxxx.xxx.